13D·WATCH Activist + Insider Intelligence Live feed Blog About Pricing
SCHEDULE 13D/A Filed 2026-09-16 Event 2026-09-14 SEC 0001398344-26-017130 →

WEXFORD CAPITAL LP Nephros, Inc. NEPH

Stake: Shares: 223,539 Class: Common stock, par value $0.001 per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)
0 transactions
0 buys · 0 sales · 0 awards/exercises
Issuer Cluster
6 13D/G filings on this issuer
5 other filings besides this one
Filer Track Record
5 filings by this filer
4 other filings in the data moat
Short Interest · settle 2026-08-31
DTC 1.00
40,967 shares short · -8.5% vs prior

Other 13D/G Filings on Nephros, Inc.

FiledFormFilerStakeShares
2021-06-11 SC Evans Daron view →
2020-10-26 SC WEXFORD CAPITAL LP view →
2020-10-21 SC PESSIN NORMAN H view →
2019-05-20 SC PESSIN NORMAN H view →
2018-01-12 SC WEXFORD CAPITAL LP view →

Other Filings by WEXFORD CAPITAL LP

FiledFormIssuerStakeShares
2020-10-26 SC NEPHROS INC NEPH view →
2018-04-17 SC FAMOUS DAVES OF AMERICA INC view →
2018-03-19 SC FAMOUS DAVES OF AMERICA INC view →
2018-01-12 SC NEPHROS INC NEPH view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →